Short answer
Cigna (CI) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Brian Evanko, 49, named CEO effective July 1, 2026; succeeds David Cordani, who becomes Executive Chair.
Cigna 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Brian Evanko, 49, named CEO effective July 1, 2026; succeeds David Cordani, who becomes Executive Chair
- Evanko total target compensation: $1.3M base salary + $2.6M EIP + $15.1M LTI annually
- One-time transitional equity award of $3.5M granted to Evanko upon CEO assumption
- Cordani's post-retirement pay: $1.0M base + $2.0M EIP; retains LTI eligibility as Executive Chair
- Planned succession with long internal tenure: Evanko has held CFO, COO, and divisional CEO roles since 2013
Item 7.01 · Regulation FD Disclosure
- 2026 EPS guidance reaffirmed at ≥$30.25 adjusted income from operations per share
- Evernorth segment 2026 pre-tax adjusted income reaffirmed at ≥$6.9B
- Cigna Healthcare segment 2026 pre-tax adjusted income reaffirmed at ≥$4.5B
- Reaffirmation signals management confidence despite healthcare sector macro pressures (cost inflation, regulatory risk, drug pricing)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cigna 8-K filings
Get the next CI 8-K as it lands
Follow CI for push alerts, or ask the research agent what this filing means.